Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Poli

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
Plos One|February 17, 2018
Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral loadNadia Galizzi, Laura Galli, Andrea Poli, et al.
Journal of the International AIDS Society|August 2, 2015
Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapyNicola Gianotti, Andrea Poli, Silvia Nozza, et al.
Journal of the Neurological Sciences|March 18, 2019
MR microneurography and quantitative T2 and DP measurements of the distal tibial nerve in CIDPPaolo Florent Felisaz, Andrea Poli, Raimondo Vitale, et al.
Journal of Medical Virology|July 10, 2019
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimensNicola Gianotti, Camilla Muccini, Laura Galli, et al.
Atherosclerosis Plus|July 3, 2026
LDL-cholesterol distance to target: A practical tool for guiding lipid-lowering treatment decisionsMaria Chiara Palloni, Teresa Farella, Andrea Faggiano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2018
Brief Report: Hyperbilirubinemia Is Associated With a Decreased Risk of Carotid Atherosclerosis in HIV-Infected Patients on Virological SuppressionCamilla Muccini, Laura Galli, Andrea Poli, et al.
Journal of the Neurological Sciences|June 11, 2019
Corrigendum to "MR microneurography and quantitative T2 and DP measurements of the distal tibial nerve in CIDP" [Journal of the Neurological Sciences Volume 400, 15 May 2019, Pages 15-20]Paolo Florent Felisaz, Andrea Poli, Raimondo Vitale, et al.
AIDS (London, England)|April 8, 2021
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimenNicola Gianotti, Laura Galli, Andrea Poli, et al.
International Journal of Antimicrobial Agents|June 21, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life settingTommaso Clemente, Laura Galli, Andrea Poli, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2020
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patientsFrancesco Saladini, Alessia Giannini, Federica Giammarino, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Plos One|February 17, 2018
Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral loadNadia Galizzi, Laura Galli, Andrea Poli, et al.
Journal of the International AIDS Society|August 2, 2015
Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapyNicola Gianotti, Andrea Poli, Silvia Nozza, et al.
Journal of the Neurological Sciences|March 18, 2019
MR microneurography and quantitative T2 and DP measurements of the distal tibial nerve in CIDPPaolo Florent Felisaz, Andrea Poli, Raimondo Vitale, et al.
Journal of Medical Virology|July 10, 2019
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimensNicola Gianotti, Camilla Muccini, Laura Galli, et al.
Atherosclerosis Plus|July 3, 2026
LDL-cholesterol distance to target: A practical tool for guiding lipid-lowering treatment decisionsMaria Chiara Palloni, Teresa Farella, Andrea Faggiano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2018
Brief Report: Hyperbilirubinemia Is Associated With a Decreased Risk of Carotid Atherosclerosis in HIV-Infected Patients on Virological SuppressionCamilla Muccini, Laura Galli, Andrea Poli, et al.
Journal of the Neurological Sciences|June 11, 2019
Corrigendum to "MR microneurography and quantitative T2 and DP measurements of the distal tibial nerve in CIDP" [Journal of the Neurological Sciences Volume 400, 15 May 2019, Pages 15-20]Paolo Florent Felisaz, Andrea Poli, Raimondo Vitale, et al.
AIDS (London, England)|April 8, 2021
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimenNicola Gianotti, Laura Galli, Andrea Poli, et al.
International Journal of Antimicrobial Agents|June 21, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life settingTommaso Clemente, Laura Galli, Andrea Poli, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2020
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patientsFrancesco Saladini, Alessia Giannini, Federica Giammarino, et al.
Pageof 19